Last $144.20 USD
Change Today -0.85 / -0.59%
Volume 263.0
BAYZF On Other Exchanges
Symbol
Exchange
BrsaItaliana
Xetra
Mexico
Continuous
As of 11:35 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bayer ag-reg (BAYZF)

Year over year, Bayer AG has seen revenues remain relatively flat ($51.0B USD to $51.5B USD), though the company was able to grow net income from $3.1B USD to $4.1B USD. A reduction in the percentage of sales devoted to selling, general and administrative costs from 30.79% to 30.53% was a key component in the bottom line growth in the face of flat revenues.
View Income Statement In Euro
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
USD
Dec 31
2011
Reclassified
USD
Dec 31
2012
Restated
USD
Dec 31
2013
USD
4 Year
Trend
Revenues45,040.746,889.251,013.551,547.5
TOTAL REVENUES45,040.746,889.251,013.551,547.5
Cost of Goods Sold21,954.323,073.624,479.224,814.2
GROSS PROFIT23,086.423,815.626,534.326,733.3
Selling General & Admin Expenses, Total13,891.714,129.115,708.015,737.5
R&D Expenses3,919.03,763.73,867.64,094.8
Other Operating Expenses269.653.9344.0-3.9
OTHER OPERATING EXPENSES, TOTAL18,080.217,946.719,919.719,828.5
OPERATING INCOME5,006.25,868.86,614.66,904.8
Interest Expense-1,116.8-1,152.7-953.8-842.1
Interest and Investment Income483.9722.7406.9329.9
NET INTEREST EXPENSE-632.8-430.0-546.8-512.2
Income (Loss) on Equity Investments-71.9-55.2-23.1-20.5
Currency Exchange Gains (Loss)-89.9-68.0-88.6-154.0
Other Non-Operating Income (Expenses)-11.6-21.8200.238.5
EBT, EXCLUDING UNUSUAL ITEMS4,200.15,293.86,156.46,256.5
Merger & Restructuring Charges-79.6---486.5-557.1
Gain (Loss) on Sale of Investments3.9-2.618.096.3
Gain (Loss) on Sale of Assets80.9220.8274.7152.8
Other Unusual Items, Total-1,996.1-1,195.1-1,885.7-548.1
Insurance Settlements----23.1--
Legal Settlements-815.1-305.5-1,666.2-354.3
Other Unusual Items-109.1-938.3146.3--
EBT, INCLUDING UNUSUAL ITEMS2,209.24,316.94,076.95,400.3
Income Tax Expense527.61,143.7928.11,310.6
Minority Interest in Earnings-11.6-2.6-64.23.9
Earnings from Continuing Operations1,681.63,173.23,148.84,089.7
NET INCOME1,670.03,170.63,084.64,093.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS1,670.03,170.63,084.64,093.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS1,670.03,170.63,084.64,093.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYZF:US $144.20 USD -0.85

BAYZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cie de St-Gobain €37.55 EUR -0.09
GlaxoSmithKline PLC 1,449 GBp +12.50
Merck & Co Inc $60.62 USD +0.31
Sanofi €88.76 EUR +0.30
Unilever PLC 2,604 GBp -8.00
View Industry Companies
 

Industry Analysis

BAYZF

Industry Average

Valuation BAYZF Industry Range
Price/Earnings 23.2x
Price/Sales 2.0x
Price/Book 4.2x
Price/Cash Flow 23.1x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.